Helmy Eltoukhy - 14 Mar 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
14 Mar 2025
Net transactions value
-$1,494,845
Form type
4
Filing time
18 Mar 2025, 17:20:22 UTC
Previous filing
13 Mar 2025
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +68,769 +2.9% $0.000000 2,429,934 14 Mar 2025 Direct
transaction GH Common Stock Tax liability $1,494,845 -34,853 -1.4% $42.89 2,395,081 14 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Performance-Based Restricted Stock Units Options Exercise $0 -68,769 -100% $0.000000 0 14 Mar 2025 Common Stock 68,769 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 Not applicable for Restricted Stock Units.